OTCMKTS:CRLBF Cresco Labs (CRLBF) Stock Price, News & Analysis $1.60 +0.03 (+1.91%) (As of 10/17/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest About Cresco Labs Stock (OTCMKTS:CRLBF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cresco Labs alerts:Sign Up Key Stats Today's Range$1.55▼$1.6650-Day Range$1.48▼$2.0052-Week Range$1.06▼$2.65Volume356,136 shsAverage Volume735,518 shsMarket Capitalization$780.29 millionP/E RatioN/ADividend YieldN/APrice Target$2.50Consensus RatingBuy Company OverviewCresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.Read More… War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Cresco Labs Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks58th Percentile Overall ScoreCRLBF MarketRank™: Cresco Labs scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingCresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCresco Labs has only been the subject of 3 research reports in the past 90 days.Read more about Cresco Labs' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cresco Labs is -3.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cresco Labs is -3.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 1.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.24% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently decreased by 5.78%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.24% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently decreased by 5.78%, indicating that investor sentiment is improving significantly. News and Social Media3.5 / 5News SentimentN/A News SentimentCresco Labs has a news sentiment score of 1.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cresco Labs this week, compared to 1 article on an average week.Search Interest4 people have searched for CRLBF on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows2 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.05% of the stock of Cresco Labs is held by institutions.Read more about Cresco Labs' insider trading history. Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address CRLBF Stock News HeadlinesCresco Labs Inc (CRLBF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...October 10, 2024 | finance.yahoo.comMichigan Cannabis Market Hits Record Sales Amid Low Weed Prices And Rise In Cultivation LicensesOctober 3, 2024 | benzinga.comWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.October 17, 2024 | Porter & Company (Ad)Cresco Labs Announces Resignation from the BoardSeptember 27, 2024 | businesswire.comCresco Labs Chief Financial Officer Dennis Olis To RetireSeptember 12, 2024 | nasdaq.comCresco Labs Announces Dennis Olis to Retire as Chief Financial OfficerSeptember 12, 2024 | finance.yahoo.comIs Cresco Labs An Overlooked Cannabis Stock? Market Potential In Ohio, Florida & Pennsylvania Promise OpportunitySeptember 9, 2024 | benzinga.comCresco Labs Remains Strong Amidst Rescheduling Uncertainties (Hold)August 29, 2024 | seekingalpha.comSee More Headlines CRLBF Stock Analysis - Frequently Asked Questions How have CRLBF shares performed this year? Cresco Labs' stock was trading at $1.3558 at the beginning of 2024. Since then, CRLBF shares have increased by 17.9% and is now trading at $1.5985. View the best growth stocks for 2024 here. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) issued its quarterly earnings results on Thursday, August, 8th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.15. The business earned $184.36 million during the quarter, compared to analyst estimates of $184.26 million. Cresco Labs had a negative net margin of 23.07% and a negative trailing twelve-month return on equity of 17.03%. How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings8/08/2024Today10/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CRLBF CUSIPN/A CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees2,760Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$3.00 Low Stock Price Target$2.00 Potential Upside/Downside+56.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-175,520,000.00 Net Margins-23.07% Pretax Margin-17.58% Return on Equity-17.03% Return on Assets-5.13% Debt Debt-to-Equity Ratio1.76 Current Ratio2.00 Quick Ratio1.30 Sales & Book Value Annual Sales$770.89 million Price / Sales1.01 Cash Flow$0.05 per share Price / Cash Flow32.04 Book Value$1.24 per share Price / Book1.29Miscellaneous Outstanding Shares488,140,000Free FloatN/AMarket Cap$780.29 million OptionableNot Optionable Beta1.86 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (OTCMKTS:CRLBF) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredEquation for Profits: Volatility = OpportunityFREE Intro to Options Class Online Tonight Prosper Trading Academy | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cresco Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.